Efficacy of Percutaneous Injection of Triamcinolone in the Treatment of Mammillary Fistula

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01315080

Enrollment

Registered

2011-03-15

Start date

2011-03-31

Completion date

2012-09-30

Last updated

2011-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mammillary Fistula

Keywords

mammillary fistula, triamcinolone, ultrasound management, percutaneous treatment

Brief summary

The investigators recently proposed a new hypothesis on the pathogenesis of mammillary fistulae (MF) suggesting that occlusion of hair follicles by keratinous plugging may relevantly contribute to the development of MF. The investigators believe that the pathogenesis of MF mimics the behaviour of hidradenitis suppurative, as both clinical entities manifest themselves as a chronic, suppurative and recurrent inflammatory process. This new proposal has led to the present suggestion of a therapeutic alternative for MF.

Detailed description

To compare the results from a prospective observational database with two groups of patients: 1. patients with MF treated by percutaneous drainage and saline solution. 2. patients with MF treated by percutaneous drainage and saline solution plus percutaneous triamcinolone. These patients are treated following usual clinical practice in our Department. All the procedures are made through an ultrasound-guided way. During the follow-up of these cases (clinical and with ultrasound) resolution rate will be registered by the same investigator. The follow-up will be at least 6 months.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* mammillary fistula * older than 18 years * patient acceptation to the recruitment

Exclusion criteria

* diabetes mellitus * arterial hypertension * immunodepression * peptic ulcer * chronic bowel inflammatory diseases

Design outcomes

Primary

Measure	Time frame
Resolution of mammillary fistula	one year

Countries

Spain

Contacts

Primary ContactJuan D Berna, MD PhD

jdberna@um.es+34 968369500

Outcome results